IDEMIA
26.6.2020 10:32:12 CEST | Business Wire | Press release
IDEMIA teamed up with Treezor over three years ago to develop a broad range of groundbreaking products like metal cards and new look / new-feel cards – colored layers, bushed metal finish, transparent - targeting key French neobanks and fintechs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200626005102/en/
This collaboration between IDEMIA, the global leader in Augmented Identity and Treezor the French banking-as-a-service market leader, has today culminated in the launch of the first ever eco-friendly card by a fintech in France. This move ties in with both companies’ green initiatives while meeting consumer demand for sustainable solutions.
Backed by longstanding design, development and production know-how, IDEMIA was able to offer Treezor a low-natural-resource-consuming card without compromising at all on security or end-user convenience. As part of its environmental strategy, IDEMIA reaffirms its commitment to move away from today’s linear take-make-waste model and fundamentally rethink the way we design, use and reuse plastics.
Onlyone, first eco-friendly neobank1
Onlyone2 , a startup that markets itself as the first ever genuinely environmentally friendly fintech, will be the first recipient of this new 85+% recycled PVC card that is due to be launched with its existing customers in September 2020.
“We strive to adopt green practices throughout our operations by going paperless and developing digital and eco-friendly bank card solutions. Bank cards are manufactured from industrial waste-based recycled PVC in line with circular economy principles, which seek to cut waste of natural resources and minimize industrial waste. IDEMIA also obtained “Environmental Claim Validation Summary” certification from its recycled PVC supplier “UL Environment Inc.” said Amanda Gourbault, Executive Vice-President for Financial institutions activities at IDEMIA.
"We are grateful Treezor and IDEMIA give us this amazing opportunity to be the first Fintech in France to offer an eco-responsible card. With this new card, we are laying the first brick in supporting our customers towards a low-carbon lifestyle" said Kamel Nait Outaleb, Co-founder and CEO of Onlyone .
“We are proud that Onlyone will issue this very first card that embraces our and Onlyone’s values and meets today’s consumer expectations. We are thrilled to have a chance to contribute to #Tech4Good who share what we are trying to achieve. A big thank you to IDEMIA for bringing its technological expertise” said Eric Lassus, Treezor cofounder and CEO.
About IDEMIA
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.
For more information, visit www.idemia.com / Follow @IdemiaGroup on Twitter
About Onlyone:
Created at the end of 2018, Onlyone is an independent, 100% digital, ethical and positive impact Fintech. Founded by Kamel Naït-Outaleb, Amine Melouk and Matthias Rouberol, three experienced entrepreneurs in banking and digital, its mission is to create a different, more virtuous payment account model, in order to reposition the banking world at the heart of society and the realities of our time.
To meet social and environmental challenges, Onlyone is reinventing account management services, adapting them to help create a transparent and sustainable banking world. In addition to monitoring day-to-day account operations, Fintech enables its users to understand, monitor and reduce the environmental impact of their consumption thanks to an exclusive environmental impact score and change management tools. It also enables them to contribute to financing projects with a high social and environmental impact, such as carbon offsetting projects or the fight against malnutrition, in a simple way and at no extra cost. To find out more go to Onlyonecard.eu.
About Treezor
Éric Lassus and Xavier Labouret founded Treezor in 2016 and in 2019 sold it to French bank Société Générale. Today Treezor is a French white-label payment services fintech. The firm can market its services in Europe based on its electronic money operating license and its Mastercard principal member status. The firm manages the entire payment process via its platform encompassing purchase, card issue, Xpay, wire transfers, P2P, KYC and more. The firm dedicates a large proportion of its funds to developing new technologies and has 80-plus staff in Paris and Rennes. To learn more about Treezor, go to www.treezor.com , follow us on Twitter @TreezorBanking and on our LinkedIn page.
----------------------------
1
As defined by the French Prudential Supervision and Resolution Authority in its 2019 report titled “Neobanks seeking profits”, ‘neobank’ means Banking-as-a-Service platforms like Treezor.
2
Treezor payment services agent
View source version on businesswire.com: https://www.businesswire.com/news/home/20200626005102/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom